Invited commentary.
Mt Sinai Medical Center, New York, NY 10029, USA. scott.swanson@mountsinai.org
Scott
S
Swanson
D000970:Antineoplastic Agents / Q000494:pharmacology; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology*; D002460:Cell Line; D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D008168:Lung / Q000166:cytology / Q000187:drug effects; D008175:Lung Neoplasms / Q000473:pathology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D011500:Protein Synthesis Inhibitors; C012589:trichostatin A